nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—PDE4C—ganglion—epilepsy syndrome	0.02	0.144	CbGeAlD
Roflumilast—PDE4C—tongue—epilepsy syndrome	0.0198	0.143	CbGeAlD
Roflumilast—PDE4C—brainstem—epilepsy syndrome	0.00871	0.0628	CbGeAlD
Roflumilast—PDE4C—forebrain—epilepsy syndrome	0.00841	0.0606	CbGeAlD
Roflumilast—PDE4C—telencephalon—epilepsy syndrome	0.00773	0.0557	CbGeAlD
Roflumilast—PDE4D—telencephalon—epilepsy syndrome	0.0068	0.0491	CbGeAlD
Roflumilast—PDE4A—telencephalon—epilepsy syndrome	0.00602	0.0434	CbGeAlD
Roflumilast—PDE4C—midbrain—epilepsy syndrome	0.00555	0.04	CbGeAlD
Roflumilast—PDE4C—head—epilepsy syndrome	0.00481	0.0347	CbGeAlD
Roflumilast—PDE4C—nervous system—epilepsy syndrome	0.00456	0.0329	CbGeAlD
Roflumilast—PDE4C—central nervous system—epilepsy syndrome	0.00439	0.0317	CbGeAlD
Roflumilast—PDE4B—forebrain—epilepsy syndrome	0.0039	0.0282	CbGeAlD
Roflumilast—PDE4D—cerebellum—epilepsy syndrome	0.00378	0.0273	CbGeAlD
Roflumilast—PDE4B—telencephalon—epilepsy syndrome	0.00359	0.0259	CbGeAlD
Roflumilast—PDE4C—brain—epilepsy syndrome	0.00349	0.0252	CbGeAlD
Roflumilast—PDE4A—cerebellum—epilepsy syndrome	0.00335	0.0241	CbGeAlD
Roflumilast—PDE4D—brain—epilepsy syndrome	0.00307	0.0221	CbGeAlD
Roflumilast—PDE4B—medulla oblongata—epilepsy syndrome	0.00282	0.0203	CbGeAlD
Roflumilast—PDE4A—brain—epilepsy syndrome	0.00272	0.0196	CbGeAlD
Roflumilast—PDE4B—midbrain—epilepsy syndrome	0.00258	0.0186	CbGeAlD
Roflumilast—PDE4B—spinal cord—epilepsy syndrome	0.00252	0.0181	CbGeAlD
Roflumilast—PDE4B—head—epilepsy syndrome	0.00224	0.0161	CbGeAlD
Roflumilast—PDE4B—nervous system—epilepsy syndrome	0.00212	0.0153	CbGeAlD
Roflumilast—PDE4B—central nervous system—epilepsy syndrome	0.00204	0.0147	CbGeAlD
Roflumilast—PDE4B—cerebellum—epilepsy syndrome	0.00199	0.0144	CbGeAlD
Roflumilast—PDE4B—brain—epilepsy syndrome	0.00162	0.0117	CbGeAlD
Roflumilast—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000422	0.000633	CcSEcCtD
Roflumilast—Urinary tract infection—Topiramate—epilepsy syndrome	0.000422	0.000632	CcSEcCtD
Roflumilast—Rash—Propofol—epilepsy syndrome	0.00042	0.00063	CcSEcCtD
Roflumilast—Dermatitis—Propofol—epilepsy syndrome	0.00042	0.000629	CcSEcCtD
Roflumilast—Immune system disorder—Gabapentin—epilepsy syndrome	0.000418	0.000626	CcSEcCtD
Roflumilast—Headache—Propofol—epilepsy syndrome	0.000418	0.000626	CcSEcCtD
Roflumilast—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000417	0.000625	CcSEcCtD
Roflumilast—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000417	0.000624	CcSEcCtD
Roflumilast—Vomiting—Midazolam—epilepsy syndrome	0.000415	0.000621	CcSEcCtD
Roflumilast—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000415	0.000621	CcSEcCtD
Roflumilast—Asthenia—Felbamate—epilepsy syndrome	0.000414	0.000621	CcSEcCtD
Roflumilast—Myalgia—Valproic Acid—epilepsy syndrome	0.000414	0.00062	CcSEcCtD
Roflumilast—Anxiety—Valproic Acid—epilepsy syndrome	0.000412	0.000618	CcSEcCtD
Roflumilast—Tremor—Pregabalin—epilepsy syndrome	0.000412	0.000617	CcSEcCtD
Roflumilast—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000411	0.000616	CcSEcCtD
Roflumilast—Rash—Midazolam—epilepsy syndrome	0.000411	0.000616	CcSEcCtD
Roflumilast—Dizziness—Fosphenytoin—epilepsy syndrome	0.000411	0.000616	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000411	0.000616	CcSEcCtD
Roflumilast—Dermatitis—Midazolam—epilepsy syndrome	0.000411	0.000615	CcSEcCtD
Roflumilast—Urticaria—Carbamazepine—epilepsy syndrome	0.00041	0.000615	CcSEcCtD
Roflumilast—Vomiting—Levetiracetam—epilepsy syndrome	0.00041	0.000613	CcSEcCtD
Roflumilast—Discomfort—Valproic Acid—epilepsy syndrome	0.000409	0.000612	CcSEcCtD
Roflumilast—Headache—Midazolam—epilepsy syndrome	0.000409	0.000612	CcSEcCtD
Roflumilast—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000408	0.000612	CcSEcCtD
Roflumilast—Diarrhoea—Diazepam—epilepsy syndrome	0.000408	0.000611	CcSEcCtD
Roflumilast—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000408	0.000611	CcSEcCtD
Roflumilast—Ill-defined disorder—Pregabalin—epilepsy syndrome	0.000408	0.000611	CcSEcCtD
Roflumilast—Sinusitis—Topiramate—epilepsy syndrome	0.000407	0.00061	CcSEcCtD
Roflumilast—Rash—Levetiracetam—epilepsy syndrome	0.000406	0.000608	CcSEcCtD
Roflumilast—Dermatitis—Levetiracetam—epilepsy syndrome	0.000406	0.000608	CcSEcCtD
Roflumilast—Asthenia—Zonisamide—epilepsy syndrome	0.000406	0.000607	CcSEcCtD
Roflumilast—Mental disorder—Gabapentin—epilepsy syndrome	0.000406	0.000607	CcSEcCtD
Roflumilast—Headache—Levetiracetam—epilepsy syndrome	0.000404	0.000604	CcSEcCtD
Roflumilast—Malnutrition—Gabapentin—epilepsy syndrome	0.000403	0.000604	CcSEcCtD
Roflumilast—Angioedema—Pregabalin—epilepsy syndrome	0.000402	0.000601	CcSEcCtD
Roflumilast—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000401	0.000601	CcSEcCtD
Roflumilast—Dizziness—Vigabatrin—epilepsy syndrome	0.000401	0.0006	CcSEcCtD
Roflumilast—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000399	0.000597	CcSEcCtD
Roflumilast—Urticaria—Lamotrigine—epilepsy syndrome	0.000397	0.000594	CcSEcCtD
Roflumilast—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000397	0.000594	CcSEcCtD
Roflumilast—Malaise—Pregabalin—epilepsy syndrome	0.000396	0.000594	CcSEcCtD
Roflumilast—Nausea—Propofol—epilepsy syndrome	0.000396	0.000593	CcSEcCtD
Roflumilast—Tension—Gabapentin—epilepsy syndrome	0.000395	0.000592	CcSEcCtD
Roflumilast—Vomiting—Fosphenytoin—epilepsy syndrome	0.000395	0.000592	CcSEcCtD
Roflumilast—Diarrhoea—Felbamate—epilepsy syndrome	0.000395	0.000592	CcSEcCtD
Roflumilast—Vertigo—Pregabalin—epilepsy syndrome	0.000395	0.000591	CcSEcCtD
Roflumilast—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000395	0.000591	CcSEcCtD
Roflumilast—Dysgeusia—Gabapentin—epilepsy syndrome	0.000395	0.000591	CcSEcCtD
Roflumilast—Dizziness—Diazepam—epilepsy syndrome	0.000395	0.000591	CcSEcCtD
Roflumilast—Infection—Valproic Acid—epilepsy syndrome	0.000394	0.00059	CcSEcCtD
Roflumilast—Rash—Fosphenytoin—epilepsy syndrome	0.000392	0.000587	CcSEcCtD
Roflumilast—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000392	0.000587	CcSEcCtD
Roflumilast—Nervousness—Gabapentin—epilepsy syndrome	0.000391	0.000586	CcSEcCtD
Roflumilast—Asthenia—Clonazepam—epilepsy syndrome	0.000391	0.000585	CcSEcCtD
Roflumilast—Rhinitis—Topiramate—epilepsy syndrome	0.00039	0.000585	CcSEcCtD
Roflumilast—Back pain—Gabapentin—epilepsy syndrome	0.00039	0.000584	CcSEcCtD
Roflumilast—Headache—Fosphenytoin—epilepsy syndrome	0.00039	0.000583	CcSEcCtD
Roflumilast—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000389	0.000583	CcSEcCtD
Roflumilast—Palpitations—Pregabalin—epilepsy syndrome	0.000388	0.000582	CcSEcCtD
Roflumilast—Asthenia—Phenytoin—epilepsy syndrome	0.000388	0.000581	CcSEcCtD
Roflumilast—Nausea—Midazolam—epilepsy syndrome	0.000388	0.00058	CcSEcCtD
Roflumilast—Muscle spasms—Gabapentin—epilepsy syndrome	0.000387	0.00058	CcSEcCtD
Roflumilast—Diarrhoea—Zonisamide—epilepsy syndrome	0.000387	0.000579	CcSEcCtD
Roflumilast—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000386	0.000578	CcSEcCtD
Roflumilast—Vomiting—Vigabatrin—epilepsy syndrome	0.000385	0.000577	CcSEcCtD
Roflumilast—Skin disorder—Valproic Acid—epilepsy syndrome	0.000385	0.000577	CcSEcCtD
Roflumilast—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000383	0.000573	CcSEcCtD
Roflumilast—Nausea—Levetiracetam—epilepsy syndrome	0.000383	0.000573	CcSEcCtD
Roflumilast—Rash—Vigabatrin—epilepsy syndrome	0.000382	0.000572	CcSEcCtD
Roflumilast—Dizziness—Felbamate—epilepsy syndrome	0.000382	0.000572	CcSEcCtD
Roflumilast—Dermatitis—Vigabatrin—epilepsy syndrome	0.000382	0.000572	CcSEcCtD
Roflumilast—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000381	0.00057	CcSEcCtD
Roflumilast—Headache—Vigabatrin—epilepsy syndrome	0.00038	0.000569	CcSEcCtD
Roflumilast—Vomiting—Diazepam—epilepsy syndrome	0.000379	0.000568	CcSEcCtD
Roflumilast—Tremor—Gabapentin—epilepsy syndrome	0.000378	0.000565	CcSEcCtD
Roflumilast—Rash—Diazepam—epilepsy syndrome	0.000376	0.000563	CcSEcCtD
Roflumilast—Dermatitis—Diazepam—epilepsy syndrome	0.000376	0.000563	CcSEcCtD
Roflumilast—Myalgia—Pregabalin—epilepsy syndrome	0.000374	0.00056	CcSEcCtD
Roflumilast—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000374	0.00056	CcSEcCtD
Roflumilast—Dizziness—Zonisamide—epilepsy syndrome	0.000374	0.00056	CcSEcCtD
Roflumilast—Headache—Diazepam—epilepsy syndrome	0.000374	0.00056	CcSEcCtD
Roflumilast—Anxiety—Pregabalin—epilepsy syndrome	0.000373	0.000558	CcSEcCtD
Roflumilast—Diarrhoea—Clonazepam—epilepsy syndrome	0.000373	0.000558	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000372	0.000556	CcSEcCtD
Roflumilast—Asthenia—Carbamazepine—epilepsy syndrome	0.000371	0.000555	CcSEcCtD
Roflumilast—Diarrhoea—Phenytoin—epilepsy syndrome	0.00037	0.000555	CcSEcCtD
Roflumilast—Discomfort—Pregabalin—epilepsy syndrome	0.00037	0.000554	CcSEcCtD
Roflumilast—Nausea—Fosphenytoin—epilepsy syndrome	0.000369	0.000553	CcSEcCtD
Roflumilast—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000368	0.000552	CcSEcCtD
Roflumilast—Angioedema—Gabapentin—epilepsy syndrome	0.000368	0.000551	CcSEcCtD
Roflumilast—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000368	0.000551	CcSEcCtD
Roflumilast—Vomiting—Felbamate—epilepsy syndrome	0.000367	0.00055	CcSEcCtD
Roflumilast—Rash—Felbamate—epilepsy syndrome	0.000364	0.000545	CcSEcCtD
Roflumilast—Dermatitis—Felbamate—epilepsy syndrome	0.000364	0.000545	CcSEcCtD
Roflumilast—Malaise—Gabapentin—epilepsy syndrome	0.000363	0.000544	CcSEcCtD
Roflumilast—Vertigo—Gabapentin—epilepsy syndrome	0.000362	0.000542	CcSEcCtD
Roflumilast—Headache—Felbamate—epilepsy syndrome	0.000362	0.000542	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000361	0.000541	CcSEcCtD
Roflumilast—Cardiac disorder—Topiramate—epilepsy syndrome	0.000361	0.000541	CcSEcCtD
Roflumilast—Dizziness—Clonazepam—epilepsy syndrome	0.00036	0.00054	CcSEcCtD
Roflumilast—Nausea—Vigabatrin—epilepsy syndrome	0.00036	0.000539	CcSEcCtD
Roflumilast—Vomiting—Zonisamide—epilepsy syndrome	0.000359	0.000538	CcSEcCtD
Roflumilast—Insomnia—Valproic Acid—epilepsy syndrome	0.000359	0.000537	CcSEcCtD
Roflumilast—Asthenia—Lamotrigine—epilepsy syndrome	0.000358	0.000536	CcSEcCtD
Roflumilast—Dizziness—Phenytoin—epilepsy syndrome	0.000358	0.000536	CcSEcCtD
Roflumilast—Rash—Zonisamide—epilepsy syndrome	0.000356	0.000534	CcSEcCtD
Roflumilast—Infection—Pregabalin—epilepsy syndrome	0.000356	0.000534	CcSEcCtD
Roflumilast—Palpitations—Gabapentin—epilepsy syndrome	0.000356	0.000533	CcSEcCtD
Roflumilast—Dermatitis—Zonisamide—epilepsy syndrome	0.000356	0.000533	CcSEcCtD
Roflumilast—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000356	0.000533	CcSEcCtD
Roflumilast—Nausea—Diazepam—epilepsy syndrome	0.000354	0.000531	CcSEcCtD
Roflumilast—Headache—Zonisamide—epilepsy syndrome	0.000354	0.00053	CcSEcCtD
Roflumilast—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000353	0.000529	CcSEcCtD
Roflumilast—Immune system disorder—Topiramate—epilepsy syndrome	0.000352	0.000527	CcSEcCtD
Roflumilast—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000352	0.000527	CcSEcCtD
Roflumilast—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000351	0.000526	CcSEcCtD
Roflumilast—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000349	0.000523	CcSEcCtD
Roflumilast—Skin disorder—Pregabalin—epilepsy syndrome	0.000348	0.000522	CcSEcCtD
Roflumilast—Vomiting—Clonazepam—epilepsy syndrome	0.000346	0.000519	CcSEcCtD
Roflumilast—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000345	0.000516	CcSEcCtD
Roflumilast—Vomiting—Phenytoin—epilepsy syndrome	0.000344	0.000515	CcSEcCtD
Roflumilast—Rash—Clonazepam—epilepsy syndrome	0.000344	0.000514	CcSEcCtD
Roflumilast—Dermatitis—Clonazepam—epilepsy syndrome	0.000343	0.000514	CcSEcCtD
Roflumilast—Myalgia—Gabapentin—epilepsy syndrome	0.000343	0.000514	CcSEcCtD
Roflumilast—Nausea—Felbamate—epilepsy syndrome	0.000343	0.000514	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000343	0.000513	CcSEcCtD
Roflumilast—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000342	0.000513	CcSEcCtD
Roflumilast—Fatigue—Valproic Acid—epilepsy syndrome	0.000342	0.000512	CcSEcCtD
Roflumilast—Anxiety—Gabapentin—epilepsy syndrome	0.000342	0.000512	CcSEcCtD
Roflumilast—Dizziness—Carbamazepine—epilepsy syndrome	0.000342	0.000512	CcSEcCtD
Roflumilast—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000342	0.000512	CcSEcCtD
Roflumilast—Headache—Clonazepam—epilepsy syndrome	0.000341	0.000511	CcSEcCtD
Roflumilast—Rash—Phenytoin—epilepsy syndrome	0.000341	0.000511	CcSEcCtD
Roflumilast—Mental disorder—Topiramate—epilepsy syndrome	0.000341	0.000511	CcSEcCtD
Roflumilast—Dermatitis—Phenytoin—epilepsy syndrome	0.000341	0.000511	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000341	0.00051	CcSEcCtD
Roflumilast—Rash—Oxcarbazepine—epilepsy syndrome	0.000339	0.000508	CcSEcCtD
Roflumilast—Constipation—Valproic Acid—epilepsy syndrome	0.000339	0.000508	CcSEcCtD
Roflumilast—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000339	0.000508	CcSEcCtD
Roflumilast—Headache—Phenytoin—epilepsy syndrome	0.000339	0.000508	CcSEcCtD
Roflumilast—Malnutrition—Topiramate—epilepsy syndrome	0.000339	0.000508	CcSEcCtD
Roflumilast—Discomfort—Gabapentin—epilepsy syndrome	0.000339	0.000508	CcSEcCtD
Roflumilast—Headache—Oxcarbazepine—epilepsy syndrome	0.000337	0.000505	CcSEcCtD
Roflumilast—Nausea—Zonisamide—epilepsy syndrome	0.000336	0.000503	CcSEcCtD
Roflumilast—Tension—Topiramate—epilepsy syndrome	0.000333	0.000498	CcSEcCtD
Roflumilast—Dysgeusia—Topiramate—epilepsy syndrome	0.000332	0.000497	CcSEcCtD
Roflumilast—Dizziness—Lamotrigine—epilepsy syndrome	0.00033	0.000494	CcSEcCtD
Roflumilast—Nervousness—Topiramate—epilepsy syndrome	0.000329	0.000493	CcSEcCtD
Roflumilast—Vomiting—Carbamazepine—epilepsy syndrome	0.000328	0.000492	CcSEcCtD
Roflumilast—Back pain—Topiramate—epilepsy syndrome	0.000328	0.000491	CcSEcCtD
Roflumilast—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000327	0.00049	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000327	0.000489	CcSEcCtD
Roflumilast—Infection—Gabapentin—epilepsy syndrome	0.000327	0.000489	CcSEcCtD
Roflumilast—Muscle spasms—Topiramate—epilepsy syndrome	0.000326	0.000488	CcSEcCtD
Roflumilast—Rash—Carbamazepine—epilepsy syndrome	0.000326	0.000488	CcSEcCtD
Roflumilast—Dermatitis—Carbamazepine—epilepsy syndrome	0.000325	0.000487	CcSEcCtD
Roflumilast—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000324	0.000486	CcSEcCtD
Roflumilast—Insomnia—Pregabalin—epilepsy syndrome	0.000324	0.000486	CcSEcCtD
Roflumilast—Nausea—Clonazepam—epilepsy syndrome	0.000324	0.000485	CcSEcCtD
Roflumilast—Headache—Carbamazepine—epilepsy syndrome	0.000324	0.000485	CcSEcCtD
Roflumilast—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000323	0.000483	CcSEcCtD
Roflumilast—Nausea—Phenytoin—epilepsy syndrome	0.000321	0.000481	CcSEcCtD
Roflumilast—Nausea—Oxcarbazepine—epilepsy syndrome	0.00032	0.000479	CcSEcCtD
Roflumilast—Skin disorder—Gabapentin—epilepsy syndrome	0.000319	0.000478	CcSEcCtD
Roflumilast—Tremor—Topiramate—epilepsy syndrome	0.000318	0.000476	CcSEcCtD
Roflumilast—Vomiting—Lamotrigine—epilepsy syndrome	0.000317	0.000475	CcSEcCtD
Roflumilast—Urticaria—Valproic Acid—epilepsy syndrome	0.000315	0.000472	CcSEcCtD
Roflumilast—Rash—Lamotrigine—epilepsy syndrome	0.000315	0.000471	CcSEcCtD
Roflumilast—Ill-defined disorder—Topiramate—epilepsy syndrome	0.000315	0.000471	CcSEcCtD
Roflumilast—Dermatitis—Lamotrigine—epilepsy syndrome	0.000315	0.000471	CcSEcCtD
Roflumilast—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000314	0.00047	CcSEcCtD
Roflumilast—Headache—Lamotrigine—epilepsy syndrome	0.000313	0.000468	CcSEcCtD
Roflumilast—Decreased appetite—Pregabalin—epilepsy syndrome	0.000312	0.000467	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.00031	0.000464	CcSEcCtD
Roflumilast—Fatigue—Pregabalin—epilepsy syndrome	0.000309	0.000463	CcSEcCtD
Roflumilast—Nausea—Carbamazepine—epilepsy syndrome	0.000307	0.00046	CcSEcCtD
Roflumilast—Constipation—Pregabalin—epilepsy syndrome	0.000307	0.000459	CcSEcCtD
Roflumilast—Malaise—Topiramate—epilepsy syndrome	0.000306	0.000458	CcSEcCtD
Roflumilast—Vertigo—Topiramate—epilepsy syndrome	0.000305	0.000456	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.0003	0.000449	CcSEcCtD
Roflumilast—Palpitations—Topiramate—epilepsy syndrome	0.0003	0.000449	CcSEcCtD
Roflumilast—Insomnia—Gabapentin—epilepsy syndrome	0.000297	0.000445	CcSEcCtD
Roflumilast—Nausea—Lamotrigine—epilepsy syndrome	0.000297	0.000444	CcSEcCtD
Roflumilast—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000296	0.000443	CcSEcCtD
Roflumilast—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000293	0.000439	CcSEcCtD
Roflumilast—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000292	0.000438	CcSEcCtD
Roflumilast—Dyspepsia—Gabapentin—epilepsy syndrome	0.00029	0.000434	CcSEcCtD
Roflumilast—Myalgia—Topiramate—epilepsy syndrome	0.000289	0.000432	CcSEcCtD
Roflumilast—Anxiety—Topiramate—epilepsy syndrome	0.000288	0.000431	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000287	0.000429	CcSEcCtD
Roflumilast—Decreased appetite—Gabapentin—epilepsy syndrome	0.000286	0.000428	CcSEcCtD
Roflumilast—Discomfort—Topiramate—epilepsy syndrome	0.000285	0.000427	CcSEcCtD
Roflumilast—Urticaria—Pregabalin—epilepsy syndrome	0.000285	0.000427	CcSEcCtD
Roflumilast—Asthenia—Valproic Acid—epilepsy syndrome	0.000285	0.000426	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000284	0.000425	CcSEcCtD
Roflumilast—Fatigue—Gabapentin—epilepsy syndrome	0.000284	0.000425	CcSEcCtD
Roflumilast—Abdominal pain—Pregabalin—epilepsy syndrome	0.000284	0.000425	CcSEcCtD
Roflumilast—Constipation—Gabapentin—epilepsy syndrome	0.000281	0.000421	CcSEcCtD
Roflumilast—Infection—Topiramate—epilepsy syndrome	0.000275	0.000412	CcSEcCtD
Roflumilast—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000271	0.000407	CcSEcCtD
Roflumilast—Nervous system disorder—Topiramate—epilepsy syndrome	0.000271	0.000406	CcSEcCtD
Roflumilast—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000271	0.000406	CcSEcCtD
Roflumilast—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000269	0.000403	CcSEcCtD
Roflumilast—Skin disorder—Topiramate—epilepsy syndrome	0.000269	0.000402	CcSEcCtD
Roflumilast—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000264	0.000396	CcSEcCtD
Roflumilast—Dizziness—Valproic Acid—epilepsy syndrome	0.000262	0.000393	CcSEcCtD
Roflumilast—Urticaria—Gabapentin—epilepsy syndrome	0.000261	0.000391	CcSEcCtD
Roflumilast—Abdominal pain—Gabapentin—epilepsy syndrome	0.00026	0.000389	CcSEcCtD
Roflumilast—Asthenia—Pregabalin—epilepsy syndrome	0.000257	0.000385	CcSEcCtD
Roflumilast—Vomiting—Valproic Acid—epilepsy syndrome	0.000252	0.000378	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000252	0.000378	CcSEcCtD
Roflumilast—Insomnia—Topiramate—epilepsy syndrome	0.00025	0.000375	CcSEcCtD
Roflumilast—Rash—Valproic Acid—epilepsy syndrome	0.00025	0.000375	CcSEcCtD
Roflumilast—Dermatitis—Valproic Acid—epilepsy syndrome	0.00025	0.000374	CcSEcCtD
Roflumilast—Headache—Valproic Acid—epilepsy syndrome	0.000249	0.000372	CcSEcCtD
Roflumilast—Diarrhoea—Pregabalin—epilepsy syndrome	0.000245	0.000368	CcSEcCtD
Roflumilast—Dyspepsia—Topiramate—epilepsy syndrome	0.000244	0.000365	CcSEcCtD
Roflumilast—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000242	0.000363	CcSEcCtD
Roflumilast—Decreased appetite—Topiramate—epilepsy syndrome	0.000241	0.00036	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000239	0.000358	CcSEcCtD
Roflumilast—Fatigue—Topiramate—epilepsy syndrome	0.000239	0.000357	CcSEcCtD
Roflumilast—Dizziness—Pregabalin—epilepsy syndrome	0.000237	0.000355	CcSEcCtD
Roflumilast—Constipation—Topiramate—epilepsy syndrome	0.000237	0.000354	CcSEcCtD
Roflumilast—Asthenia—Gabapentin—epilepsy syndrome	0.000236	0.000353	CcSEcCtD
Roflumilast—Nausea—Valproic Acid—epilepsy syndrome	0.000236	0.000353	CcSEcCtD
Roflumilast—Vomiting—Pregabalin—epilepsy syndrome	0.000228	0.000342	CcSEcCtD
Roflumilast—Feeling abnormal—Topiramate—epilepsy syndrome	0.000228	0.000341	CcSEcCtD
Roflumilast—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000226	0.000339	CcSEcCtD
Roflumilast—Rash—Pregabalin—epilepsy syndrome	0.000226	0.000339	CcSEcCtD
Roflumilast—Dermatitis—Pregabalin—epilepsy syndrome	0.000226	0.000338	CcSEcCtD
Roflumilast—Diarrhoea—Gabapentin—epilepsy syndrome	0.000225	0.000337	CcSEcCtD
Roflumilast—Headache—Pregabalin—epilepsy syndrome	0.000225	0.000336	CcSEcCtD
Roflumilast—Urticaria—Topiramate—epilepsy syndrome	0.00022	0.000329	CcSEcCtD
Roflumilast—Abdominal pain—Topiramate—epilepsy syndrome	0.000219	0.000328	CcSEcCtD
Roflumilast—Dizziness—Gabapentin—epilepsy syndrome	0.000217	0.000326	CcSEcCtD
Roflumilast—Nausea—Pregabalin—epilepsy syndrome	0.000213	0.000319	CcSEcCtD
Roflumilast—Vomiting—Gabapentin—epilepsy syndrome	0.000209	0.000313	CcSEcCtD
Roflumilast—Rash—Gabapentin—epilepsy syndrome	0.000207	0.000311	CcSEcCtD
Roflumilast—Dermatitis—Gabapentin—epilepsy syndrome	0.000207	0.00031	CcSEcCtD
Roflumilast—Headache—Gabapentin—epilepsy syndrome	0.000206	0.000309	CcSEcCtD
Roflumilast—Hypersensitivity—Topiramate—epilepsy syndrome	0.000204	0.000305	CcSEcCtD
Roflumilast—Asthenia—Topiramate—epilepsy syndrome	0.000199	0.000297	CcSEcCtD
Roflumilast—Nausea—Gabapentin—epilepsy syndrome	0.000195	0.000293	CcSEcCtD
Roflumilast—Diarrhoea—Topiramate—epilepsy syndrome	0.000189	0.000284	CcSEcCtD
Roflumilast—Dizziness—Topiramate—epilepsy syndrome	0.000183	0.000274	CcSEcCtD
Roflumilast—Vomiting—Topiramate—epilepsy syndrome	0.000176	0.000263	CcSEcCtD
Roflumilast—Rash—Topiramate—epilepsy syndrome	0.000174	0.000261	CcSEcCtD
Roflumilast—Dermatitis—Topiramate—epilepsy syndrome	0.000174	0.000261	CcSEcCtD
Roflumilast—Headache—Topiramate—epilepsy syndrome	0.000173	0.00026	CcSEcCtD
Roflumilast—Nausea—Topiramate—epilepsy syndrome	0.000164	0.000246	CcSEcCtD
Roflumilast—PDE4A—GPCR downstream signaling—CCR5—epilepsy syndrome	0.000103	0.000531	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—DUSP6—epilepsy syndrome	0.000102	0.000529	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—AVP—epilepsy syndrome	0.000102	0.000525	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ADRA2A—epilepsy syndrome	0.000101	0.000523	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCR3—epilepsy syndrome	0.000101	0.00052	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PLAT—epilepsy syndrome	0.000101	0.00052	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—HTR2A—epilepsy syndrome	0.000101	0.00052	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—AGT—epilepsy syndrome	0.0001	0.000518	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HRH3—epilepsy syndrome	0.0001	0.000518	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CCL3—epilepsy syndrome	9.95e-05	0.000514	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CRH—epilepsy syndrome	9.95e-05	0.000514	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CXCL2—epilepsy syndrome	9.95e-05	0.000514	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HSPB1—epilepsy syndrome	9.95e-05	0.000514	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—OXT—epilepsy syndrome	9.95e-05	0.000514	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—OPRM1—epilepsy syndrome	9.87e-05	0.00051	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NPY—epilepsy syndrome	9.82e-05	0.000507	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ATP2A2—epilepsy syndrome	9.82e-05	0.000507	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—CCR5—epilepsy syndrome	9.81e-05	0.000507	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—BDKRB2—epilepsy syndrome	9.72e-05	0.000502	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CXCL12—epilepsy syndrome	9.72e-05	0.000502	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—POMC—epilepsy syndrome	9.7e-05	0.000501	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—PRKCB—epilepsy syndrome	9.67e-05	0.0005	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—IL6ST—epilepsy syndrome	9.63e-05	0.000498	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—HTR2A—epilepsy syndrome	9.6e-05	0.000496	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—AGT—epilepsy syndrome	9.55e-05	0.000493	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CNR1—epilepsy syndrome	9.54e-05	0.000493	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—JUNB—epilepsy syndrome	9.54e-05	0.000493	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—CCR5—epilepsy syndrome	9.52e-05	0.000492	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PLCB1—epilepsy syndrome	9.5e-05	0.000491	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HSPB1—epilepsy syndrome	9.47e-05	0.000489	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CXCL2—epilepsy syndrome	9.47e-05	0.000489	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCL3—epilepsy syndrome	9.47e-05	0.000489	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CRH—epilepsy syndrome	9.47e-05	0.000489	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—OXT—epilepsy syndrome	9.47e-05	0.000489	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—CCR5—epilepsy syndrome	9.34e-05	0.000483	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCR3—epilepsy syndrome	9.32e-05	0.000481	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—HTR2A—epilepsy syndrome	9.32e-05	0.000481	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HTR7—epilepsy syndrome	9.31e-05	0.000481	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—PRKCB—epilepsy syndrome	9.27e-05	0.000479	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PTK2B—epilepsy syndrome	9.25e-05	0.000478	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TSC1—epilepsy syndrome	9.25e-05	0.000478	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—HTR2A—epilepsy syndrome	9.14e-05	0.000472	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—AGT—epilepsy syndrome	9.11e-05	0.000471	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NPY—epilepsy syndrome	9.08e-05	0.000469	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ATP2A2—epilepsy syndrome	9.08e-05	0.000469	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HBEGF—epilepsy syndrome	9.03e-05	0.000467	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CCR2—epilepsy syndrome	9e-05	0.000465	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NTRK2—epilepsy syndrome	9e-05	0.000465	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SST—epilepsy syndrome	9e-05	0.000465	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—DUSP6—epilepsy syndrome	8.92e-05	0.000461	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AKT3—epilepsy syndrome	8.87e-05	0.000458	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—AGT—epilepsy syndrome	8.84e-05	0.000457	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—PRKCB—epilepsy syndrome	8.83e-05	0.000456	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—POMC—epilepsy syndrome	8.81e-05	0.000455	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ADRA2A—epilepsy syndrome	8.81e-05	0.000455	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TSC1—epilepsy syndrome	8.8e-05	0.000455	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PTK2B—epilepsy syndrome	8.8e-05	0.000455	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PLAT—epilepsy syndrome	8.77e-05	0.000453	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CXCL2—epilepsy syndrome	8.76e-05	0.000453	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HSPB1—epilepsy syndrome	8.76e-05	0.000453	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—OXT—epilepsy syndrome	8.76e-05	0.000453	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCL3—epilepsy syndrome	8.76e-05	0.000453	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CRH—epilepsy syndrome	8.76e-05	0.000453	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—AGT—epilepsy syndrome	8.67e-05	0.000448	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ADAM10—epilepsy syndrome	8.66e-05	0.000447	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—CCR5—epilepsy syndrome	8.64e-05	0.000447	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—CCL2—epilepsy syndrome	8.62e-05	0.000445	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NTRK2—epilepsy syndrome	8.56e-05	0.000442	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCR2—epilepsy syndrome	8.56e-05	0.000442	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SST—epilepsy syndrome	8.56e-05	0.000442	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—DUSP6—epilepsy syndrome	8.49e-05	0.000439	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CXCL12—epilepsy syndrome	8.46e-05	0.000437	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—BDKRB2—epilepsy syndrome	8.46e-05	0.000437	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—HTR2A—epilepsy syndrome	8.46e-05	0.000437	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—POMC—epilepsy syndrome	8.45e-05	0.000436	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—PRKCB—epilepsy syndrome	8.42e-05	0.000435	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—IL6ST—epilepsy syndrome	8.39e-05	0.000433	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ADRA2A—epilepsy syndrome	8.38e-05	0.000433	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PLAT—epilepsy syndrome	8.35e-05	0.000431	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—JUNB—epilepsy syndrome	8.3e-05	0.000429	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CNR1—epilepsy syndrome	8.3e-05	0.000429	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PLCB1—epilepsy syndrome	8.27e-05	0.000427	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—S100B—epilepsy syndrome	8.19e-05	0.000423	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—PRKCB—epilepsy syndrome	8.17e-05	0.000422	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TSC1—epilepsy syndrome	8.15e-05	0.000421	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PTK2B—epilepsy syndrome	8.15e-05	0.000421	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—SOCS3—epilepsy syndrome	8.11e-05	0.000419	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HTR7—epilepsy syndrome	8.1e-05	0.000418	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CDC42—epilepsy syndrome	8.09e-05	0.000418	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CXCL12—epilepsy syndrome	8.05e-05	0.000416	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—BDKRB2—epilepsy syndrome	8.05e-05	0.000416	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—POMC—epilepsy syndrome	8.04e-05	0.000415	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—AGT—epilepsy syndrome	8.03e-05	0.000415	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PRKCB—epilepsy syndrome	8.02e-05	0.000414	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—IL6ST—epilepsy syndrome	7.98e-05	0.000412	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCR2—epilepsy syndrome	7.92e-05	0.000409	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SST—epilepsy syndrome	7.92e-05	0.000409	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NTRK2—epilepsy syndrome	7.92e-05	0.000409	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—JUNB—epilepsy syndrome	7.9e-05	0.000408	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CNR1—epilepsy syndrome	7.9e-05	0.000408	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PLCB1—epilepsy syndrome	7.88e-05	0.000407	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HBEGF—epilepsy syndrome	7.86e-05	0.000406	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—DUSP6—epilepsy syndrome	7.85e-05	0.000406	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AVP—epilepsy syndrome	7.83e-05	0.000405	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ADRA2A—epilepsy syndrome	7.75e-05	0.000401	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PLAT—epilepsy syndrome	7.72e-05	0.000399	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AKT3—epilepsy syndrome	7.72e-05	0.000399	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HTR7—epilepsy syndrome	7.71e-05	0.000398	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—POMC—epilepsy syndrome	7.67e-05	0.000396	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ADAM10—epilepsy syndrome	7.54e-05	0.00039	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—CCL2—epilepsy syndrome	7.51e-05	0.000388	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HBEGF—epilepsy syndrome	7.49e-05	0.000387	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—BDKRB2—epilepsy syndrome	7.45e-05	0.000385	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CXCL12—epilepsy syndrome	7.45e-05	0.000385	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—POMC—epilepsy syndrome	7.44e-05	0.000384	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PRKCB—epilepsy syndrome	7.42e-05	0.000383	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HES1—epilepsy syndrome	7.41e-05	0.000383	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—IL6ST—epilepsy syndrome	7.39e-05	0.000382	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AKT3—epilepsy syndrome	7.35e-05	0.00038	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—JUNB—epilepsy syndrome	7.31e-05	0.000378	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CNR1—epilepsy syndrome	7.31e-05	0.000378	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—POMC—epilepsy syndrome	7.3e-05	0.000377	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PLCB1—epilepsy syndrome	7.29e-05	0.000376	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—FYN—epilepsy syndrome	7.2e-05	0.000372	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ADAM10—epilepsy syndrome	7.18e-05	0.000371	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—H2AFX—epilepsy syndrome	7.18e-05	0.000371	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MEF2C—epilepsy syndrome	7.16e-05	0.00037	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—CCL2—epilepsy syndrome	7.14e-05	0.000369	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HTR7—epilepsy syndrome	7.13e-05	0.000369	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—S100B—epilepsy syndrome	7.13e-05	0.000368	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SOCS3—epilepsy syndrome	7.06e-05	0.000365	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CDC42—epilepsy syndrome	7.04e-05	0.000364	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HBEGF—epilepsy syndrome	6.93e-05	0.000358	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—YWHAZ—epilepsy syndrome	6.92e-05	0.000358	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NGF—epilepsy syndrome	6.85e-05	0.000354	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AVP—epilepsy syndrome	6.82e-05	0.000352	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AKT3—epilepsy syndrome	6.8e-05	0.000351	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—S100B—epilepsy syndrome	6.79e-05	0.000351	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—POMC—epilepsy syndrome	6.76e-05	0.000349	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SOCS3—epilepsy syndrome	6.72e-05	0.000347	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CDC42—epilepsy syndrome	6.7e-05	0.000346	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CCR5—epilepsy syndrome	6.66e-05	0.000344	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ADAM10—epilepsy syndrome	6.64e-05	0.000343	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—CCL2—epilepsy syndrome	6.61e-05	0.000341	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HTR2A—epilepsy syndrome	6.52e-05	0.000337	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AVP—epilepsy syndrome	6.49e-05	0.000335	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HES1—epilepsy syndrome	6.45e-05	0.000333	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—S100B—epilepsy syndrome	6.28e-05	0.000324	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—FYN—epilepsy syndrome	6.27e-05	0.000324	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—H2AFX—epilepsy syndrome	6.25e-05	0.000323	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MEF2C—epilepsy syndrome	6.24e-05	0.000322	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SOCS3—epilepsy syndrome	6.22e-05	0.000321	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CDC42—epilepsy syndrome	6.2e-05	0.00032	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TSC2—epilepsy syndrome	6.19e-05	0.00032	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AGT—epilepsy syndrome	6.18e-05	0.000319	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HES1—epilepsy syndrome	6.14e-05	0.000317	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—APOE—epilepsy syndrome	6.06e-05	0.000313	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—YWHAZ—epilepsy syndrome	6.03e-05	0.000311	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AVP—epilepsy syndrome	6.01e-05	0.00031	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—FYN—epilepsy syndrome	5.97e-05	0.000308	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NGF—epilepsy syndrome	5.96e-05	0.000308	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—H2AFX—epilepsy syndrome	5.95e-05	0.000307	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—KDR—epilepsy syndrome	5.94e-05	0.000307	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MEF2C—epilepsy syndrome	5.94e-05	0.000307	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CCR5—epilepsy syndrome	5.8e-05	0.0003	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—YWHAZ—epilepsy syndrome	5.74e-05	0.000296	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PRKCB—epilepsy syndrome	5.71e-05	0.000295	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IL6ST—epilepsy syndrome	5.69e-05	0.000294	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HES1—epilepsy syndrome	5.68e-05	0.000293	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HTR2A—epilepsy syndrome	5.67e-05	0.000293	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NGF—epilepsy syndrome	5.67e-05	0.000293	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—FYN—epilepsy syndrome	5.52e-05	0.000285	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCR5—epilepsy syndrome	5.52e-05	0.000285	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—H2AFX—epilepsy syndrome	5.5e-05	0.000284	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MEF2C—epilepsy syndrome	5.49e-05	0.000284	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HTR2A—epilepsy syndrome	5.4e-05	0.000279	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TSC2—epilepsy syndrome	5.39e-05	0.000278	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AGT—epilepsy syndrome	5.38e-05	0.000278	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—YWHAZ—epilepsy syndrome	5.31e-05	0.000274	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—APOE—epilepsy syndrome	5.27e-05	0.000272	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NGF—epilepsy syndrome	5.25e-05	0.000271	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—POMC—epilepsy syndrome	5.21e-05	0.000269	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—KDR—epilepsy syndrome	5.17e-05	0.000267	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TSC2—epilepsy syndrome	5.13e-05	0.000265	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AGT—epilepsy syndrome	5.12e-05	0.000265	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCR5—epilepsy syndrome	5.11e-05	0.000264	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CCL2—epilepsy syndrome	5.09e-05	0.000263	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—APOE—epilepsy syndrome	5.02e-05	0.000259	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HTR2A—epilepsy syndrome	5e-05	0.000258	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PRKCB—epilepsy syndrome	4.97e-05	0.000257	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IL6ST—epilepsy syndrome	4.95e-05	0.000256	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—KDR—epilepsy syndrome	4.92e-05	0.000254	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TSC2—epilepsy syndrome	4.75e-05	0.000245	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AGT—epilepsy syndrome	4.74e-05	0.000245	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PRKCB—epilepsy syndrome	4.73e-05	0.000245	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IL6ST—epilepsy syndrome	4.72e-05	0.000244	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—APOE—epilepsy syndrome	4.65e-05	0.00024	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—FGF2—epilepsy syndrome	4.6e-05	0.000238	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—KDR—epilepsy syndrome	4.55e-05	0.000235	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—POMC—epilepsy syndrome	4.53e-05	0.000234	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CCL2—epilepsy syndrome	4.43e-05	0.000229	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PRKCB—epilepsy syndrome	4.38e-05	0.000226	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IL6ST—epilepsy syndrome	4.36e-05	0.000225	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—POMC—epilepsy syndrome	4.31e-05	0.000223	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—RELA—epilepsy syndrome	4.27e-05	0.000221	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCL2—epilepsy syndrome	4.22e-05	0.000218	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MTOR—epilepsy syndrome	4.19e-05	0.000216	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—FGF2—epilepsy syndrome	4.01e-05	0.000207	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—POMC—epilepsy syndrome	3.99e-05	0.000206	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCL2—epilepsy syndrome	3.9e-05	0.000202	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—AKT1—epilepsy syndrome	3.89e-05	0.000201	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CASP3—epilepsy syndrome	3.85e-05	0.000199	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—FGF2—epilepsy syndrome	3.81e-05	0.000197	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—JUN—epilepsy syndrome	3.74e-05	0.000193	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—RELA—epilepsy syndrome	3.72e-05	0.000192	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MTOR—epilepsy syndrome	3.65e-05	0.000188	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MMP9—epilepsy syndrome	3.64e-05	0.000188	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—RELA—epilepsy syndrome	3.54e-05	0.000183	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—AKT1—epilepsy syndrome	3.53e-05	0.000182	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—FGF2—epilepsy syndrome	3.53e-05	0.000182	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MTOR—epilepsy syndrome	3.47e-05	0.000179	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—AKT1—epilepsy syndrome	3.39e-05	0.000175	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—SRC—epilepsy syndrome	3.36e-05	0.000173	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CASP3—epilepsy syndrome	3.36e-05	0.000173	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—RELA—epilepsy syndrome	3.28e-05	0.000169	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—VEGFA—epilepsy syndrome	3.27e-05	0.000169	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—JUN—epilepsy syndrome	3.26e-05	0.000168	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.22e-05	0.000167	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MTOR—epilepsy syndrome	3.21e-05	0.000166	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CASP3—epilepsy syndrome	3.19e-05	0.000165	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MMP9—epilepsy syndrome	3.17e-05	0.000164	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—JUN—epilepsy syndrome	3.1e-05	0.00016	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—AKT1—epilepsy syndrome	3.08e-05	0.000159	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MMP9—epilepsy syndrome	3.02e-05	0.000156	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—AKT1—epilepsy syndrome	2.98e-05	0.000154	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CASP3—epilepsy syndrome	2.95e-05	0.000153	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—AKT1—epilepsy syndrome	2.93e-05	0.000151	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SRC—epilepsy syndrome	2.92e-05	0.000151	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—JUN—epilepsy syndrome	2.87e-05	0.000148	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—VEGFA—epilepsy syndrome	2.85e-05	0.000147	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MMP9—epilepsy syndrome	2.79e-05	0.000144	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SRC—epilepsy syndrome	2.78e-05	0.000144	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—VEGFA—epilepsy syndrome	2.71e-05	0.00014	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—AKT1—epilepsy syndrome	2.71e-05	0.00014	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SRC—epilepsy syndrome	2.57e-05	0.000133	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—VEGFA—epilepsy syndrome	2.51e-05	0.00013	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AKT1—epilepsy syndrome	2.09e-05	0.000108	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AKT1—epilepsy syndrome	1.82e-05	9.38e-05	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AKT1—epilepsy syndrome	1.73e-05	8.93e-05	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AKT1—epilepsy syndrome	1.6e-05	8.26e-05	CbGpPWpGaD
